Recursion Pharmaceuticals Stock Technical Analysis

RXRX Stock  USD 5.50  0.18  3.38%   
As of the 18th of April 2025, Recursion Pharmaceuticals holds the Semi Deviation of 6.04, risk adjusted performance of 0.015, and Coefficient Of Variation of 22052.95. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Recursion Pharmaceuticals, as well as the relationship between them.

Recursion Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Recursion, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RecursionRecursion Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Recursion Pharmaceuticals Analyst Consensus

Target PriceAdvice# of Analysts
9.29Buy8Odds
Recursion Pharmaceuticals current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Recursion analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Recursion stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Recursion Pharmaceuticals, talking to its executives and customers, or listening to Recursion conference calls.
JavaScript chart by amCharts 3.21.15116Strong BuyBuyHold0123456
Recursion Analyst Advice Details
Recursion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Recursion Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Recursion Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Recursion Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Recursion Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
JavaScript chart by amCharts 3.21.15FebMarAprMar 10Mar 17Mar 24Mar 31AprApr 144.04.55.05.56.06.5 20M30M40M50M60M70M80M 0.650.700.750.800.850.90 38K39K40K41K42K Show all
JavaScript chart by amCharts 3.21.15Recursion Pharmaceuticals Volume Recursion Pharmaceuticals Closing Prices Dow Jones Industrial Closing Prices - Benchmark Recursion Pharmaceuticals Average True Range

Recursion Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Recursion Pharmaceuticals. You can use it to identify possible trend reversals for Recursion Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Recursion Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15FebMarApr456789
JavaScript chart by amCharts 3.21.15FebMarApr

Recursion Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Recursion Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.06  , which may suggest that Recursion Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 140.73, which is the sum of squared deviations for the predicted Recursion Pharmaceuticals price change compared to its average price change.
JavaScript chart by amCharts 3.21.15 Prediction Change
JavaScript chart by amCharts 3.21.15FebMarApr-50%-40%-30%-20%-10%0%10%20%30%40%
JavaScript chart by amCharts 3.21.15FebMarApr

About Recursion Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Recursion Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Recursion Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Recursion Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Recursion Pharmaceuticals. By analyzing Recursion Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Recursion Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Recursion Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2024 2025 (projected)
Payables Turnover10.532.091.99
Days Of Inventory On Hand9.6811.1310.57

Recursion Pharmaceuticals April 18, 2025 Technical Indicators

Most technical analysis of Recursion help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Recursion from various momentum indicators to cycle indicators. When you analyze Recursion charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Recursion Pharmaceuticals April 18, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Recursion stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for Recursion Stock Analysis

When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.